These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 16353320)
1. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Kleindorfer DO; Khatri P; Katzan I Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320 [No Abstract] [Full Text] [Related]
2. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Schestatsky P; Picon PD Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546 [No Abstract] [Full Text] [Related]
3. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Whitcomb DS Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750 [No Abstract] [Full Text] [Related]
4. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke. Bledsoe BE Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219 [No Abstract] [Full Text] [Related]
5. Breaking the 3 h barrier for treatment of acute ischaemic stroke. Donnan GA; Davis SM Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690 [No Abstract] [Full Text] [Related]
6. Should more patients with acute ischaemic stroke receive thrombolytic treatment? Wardlaw JM; Sandercock PA; Murray V BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748 [No Abstract] [Full Text] [Related]
7. Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Demaerschalk BM Stroke; 2007 Aug; 38(8):2215-6. PubMed ID: 17641237 [No Abstract] [Full Text] [Related]
8. When is enough enough? Donnan GA; Davis SM Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042 [No Abstract] [Full Text] [Related]
9. Treatment of acute ischemic stroke: Part I: recanalization strategies. Broderick JP; Hacke W Circulation; 2002 Sep; 106(12):1563-9. PubMed ID: 12234965 [No Abstract] [Full Text] [Related]
10. Further randomized controlled trials of tPA within 3 hours are required-not! Lyden PD Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041 [No Abstract] [Full Text] [Related]
11. 4.5 hours: the new time window for tissue plasminogen activator in stroke. Davis SM; Donnan GA Stroke; 2009 Jun; 40(6):2266-7. PubMed ID: 19407232 [No Abstract] [Full Text] [Related]
12. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke. Zhang B; Sun XJ; Ju CH Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577 [TBL] [Abstract][Full Text] [Related]
14. Randomised trials of endovascular treatment of stroke are needed. Schott AM Lancet Neurol; 2010 Jan; 9(1):30-1. PubMed ID: 20083032 [No Abstract] [Full Text] [Related]
15. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke. You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479 [TBL] [Abstract][Full Text] [Related]
16. rtPA in acute stroke patients with history of cognitive impairment: do not hesitate to treat. Román GC; Hakim AM Neurology; 2014 Jun; 82(23):2044-5. PubMed ID: 24827496 [No Abstract] [Full Text] [Related]
17. Thrombolysis (tissue plasminogen activator) in stroke: a medicolegal quagmire. Weintraub MI Stroke; 2006 Jul; 37(7):1917-22. PubMed ID: 16728683 [TBL] [Abstract][Full Text] [Related]
18. [Thrombolytic therapy in acute ischemic stroke: present and future]. Mori E No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978 [No Abstract] [Full Text] [Related]
19. Solving the issue of patient arrival time: a call for vigilant action. Alexandrov AW Stroke; 2007 Aug; 38(8):2219-20. PubMed ID: 17615363 [No Abstract] [Full Text] [Related]
20. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study]. Di Pasquale G Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744 [No Abstract] [Full Text] [Related] [Next] [New Search]